Literature DB >> 1741161

Transcriptional activity of rel family proteins.

P C McDonnell1, S Kumar, A B Rabson, C Gélinas.   

Abstract

Our studies originally demonstrated that the v-rel oncoprotein repressed gene expression in chicken lymphoid cells, while it activated transcription in rodent fibroblasts. Here we report that the c-rel protein can activate expression of genes linked to kappa B motifs when low levels of endogenous kappa B-binding activity are present. In contrast v-rel, and to a lesser extent c-rel, inhibit NF-kappa B-mediated activation of the human immunodeficiency virus long terminal repeat (HIV LTR) in phorbol ester-stimulated HeLa cells. Competition assays show that v-rel competitively inhibits both NF-kappa B and c-rel-mediated transcriptional activation. Analysis of mutant HIV LTR-chloramphenicol acetyltransferase (CAT) constructs in which all Sp1 or both NF-kappa B elements have been deleted shows that NF-kappa B motifs are required for rel-mediated effects on gene expression. Transforming v-rel mutants compete efficiently with phorbol ester-activated kappa B factors, whereas a transformation-defective mutant of v-rel is impaired in this activity. Taken together, these results strengthen the hypothesis that v-rel functions as a dominant interfering member of rel family proteins. These results also suggest that the ability of v- and c-rel to activate or repress gene expression in specific cells may result from their capacity to compete with endogenous rel family proteins whose expression and/or activity are cell-specific.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1741161

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  The RxxRxRxxC motif conserved in all Rel/kappa B proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoprotein.

Authors:  S Kumar; A B Rabson; C Gélinas
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

2.  AP-1 factors play an important role in transformation induced by the v-rel oncogene.

Authors:  J Kralova; A S Liss; W Bargmann; H R Bose
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

3.  Avian I kappa B alpha is transcriptionally induced by c-Rel and v-Rel with different kinetics.

Authors:  J D Schatzle; J Kralova; H R Bose
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

4.  Temperature-sensitive transforming mutants of the v-rel oncogene.

Authors:  D W White; T D Gilmore
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

5.  Evolution of the oncogenic potential of v-rel: rel-induced expression of immunoregulatory receptors correlates with tumor development and in vitro transformation.

Authors:  J Nehyba; R Hrdlicková; E H Humphries
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

6.  Transformation of avian fibroblasts overexpressing the c-rel proto-oncogene and a variant of c-rel lacking 40 C-terminal amino acids.

Authors:  J Kralova; J D Schatzle; W Bargmann; H R Bose
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

7.  Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation.

Authors:  C Kunsch; S M Ruben; C A Rosen
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

8.  Mapping of a serine-rich domain essential for the transcriptional, antiapoptotic, and transforming activities of the v-Rel oncoprotein.

Authors:  C Chen; F Agnès; C Gélinas
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

9.  v-rel induces expression of three avian immunoregulatory surface receptors more efficiently than c-rel.

Authors:  R Hrdlicková; J Nehyba; E H Humphries
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

10.  Functional interaction of the v-Rel and c-Rel oncoproteins with the TATA-binding protein and association with transcription factor IIB.

Authors:  X Xu; C Prorock; H Ishikawa; E Maldonado; Y Ito; C Gélinas
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.